Literature DB >> 7270402

Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.

N A Awan, K Needham, M K Evenson, J Hermanovich, J A Joye, A N DeMaria, D T Mason.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270402     DOI: 10.1016/0002-8703(81)90744-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  7 in total

Review 1.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

2.  Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents.

Authors:  C A Simonton
Journal:  West J Med       Date:  1985-02

Review 3.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 4.  Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

5.  Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.

Authors:  W MacNee; C G Wathen; W J Hannan; D C Flenley; A L Muir
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

6.  Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.

Authors:  J R Dawson; R Canepa-Anson; P Kuan; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-09

7.  Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.

Authors:  Manoraj Navaratnarajah; Urszula Siedlecka; Michael Ibrahim; Carin van Doorn; Gopal Soppa; Ajay Gandhi; Adarsh Shah; Punam Kukadia; Magdi H Yacoub; Cesare M Terracciano
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.